De novo radiologic placement of button gastrostomy: a feasibility study in children with cancer

Richioud, Bertrand; Louazon, Typhaine; Beji, H.; Bertrand, A.; Roux, Pascale; Kalenderian, Anne-Charlotte; Cuinet, M.; Pilleul, F.; Marec‐Bérard, Perrine

doi:10.1007/s00247-015-3426-5

Cited by 6 publications

(17 citation statements)

References 29 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A small feasibility study of radiologically placed primary button GT in 11 children and young adults with cancer (3-20 years old) showed no major complications or short-to medium-term infections and minor complications in only two patients. 48 However, another study showed much higher rates of local infection with button GT use compared with initial GT, highlighting the need for further research. 40 The incidence of persistent gastrocutaneous fistula after GT removal has been reported as high as 45% in general pediatric populations, with duration since initial insertion the only reported significant predictive factor.…”

Section: Complicationsmentioning

confidence: 99%

“…Button GT are not commonly used at initial insertion, and there is limited evidence on their use in children with cancer. A small feasibility study of radiologically placed primary button GT in 11 children and young adults with cancer (3–20 years old) showed no major complications or short‐ to medium‐term infections and minor complications in only two patients . However, another study showed much higher rates of local infection with button GT use compared with initial GT, highlighting the need for further research …”

Section: Complicationsmentioning

confidence: 99%

See 1 more Smart Citation

Gastrostomy tube use in children with cancer

McGrath

Hardikar

2019

Pediatric Blood & Cancer

View full text Add to dashboard Cite

Children with cancer are at risk of malnutrition, which can impair critical childhood processes of growth and development and contribute to poor health outcomes. Enteral nutrition can effectively ameliorate malnutrition or weight loss in children with cancer; however, published nutrition support algorithms contain minimal specific information on gastrostomy tube use, and current literature is limited. Decisions about gastrostomy tube insertion in children with cancer can be challenging. Consideration of gastrostomy tube insertion is only appropriate in children with long‐term dependence on enteral nutrition, particularly when nasogastric tube insertion is predicted or proven to be problematic. Specific indications for patient selection are unclear, and referring clinicians may be unaware of important absolute and relative contraindications. Complications are predominantly minor in nature; however, reported rates are high. Morbidity must be weighed carefully against the need and anticipated duration of enteral nutrition support, and further research in this area is needed.

show abstract

Section: Complicationsmentioning

confidence: 99%

Section: Complicationsmentioning

confidence: 99%

Gastrostomy tube use in children with cancer

McGrath

Hardikar

2019

Pediatric Blood & Cancer

View full text Add to dashboard Cite

show abstract

“…One study was translated from French 36 ; others were in English. All but two studies 17,36 were single-center, with 50% (8 of 16) undertaken in Europe, 17,22,26,[36][37][38][39][40] 44% (7 of 16) in North America, 24,25,27,[41][42][43][44] and one in Australia. 45 Study inclusion periods ranged from 3.5 to 16 years, 25,26 with average ages from 2 to 13 years.…”

Section: Study Characteristicsmentioning

confidence: 99%

“…45 Study inclusion periods ranged from 3.5 to 16 years, 25,26 with average ages from 2 to 13 years. 24,36,40 Two studies focused on children undergoing BMT, 22,24 three investigated mixed populations undergoing cancer treatment with and without BMT, 26,27,38 and 69% (11 of 16) included children undergoing treatment for various malignant diseases without BMT.…”

Section: Study Characteristicsmentioning

confidence: 99%

“…No studies were randomized, 69% (11 of 16) were case series following one group only (seven were retrospective, 25,27,38,40,[43][44][45] whereas four did not state whether they were retrospective or prospective 26,37,41,42 ), and 31% (5 of 16) were cohort studies 17,22,24,36,39 comparing two groups (only one was prospective 39 ). Comparator groups included children with gastrostomies for noncancer/non-BMT reasons (typically neurological impairment 17,24,39 ) or NGT during cancer treatment without 17 or with BMT.…”

Section: Study Characteristicsmentioning

confidence: 99%

See 1 more Smart Citation

Systematic review of gastrostomy complications and outcomes in pediatric cancer and bone marrow transplant

et al. 2021

View full text Add to dashboard Cite

Background: Nutrition support is essential in children with cancer, including those undergoing bone marrow transplant (BMT), to reduce the risk of malnutrition and associated deleterious outcomes. Enteral nutrition is more commonly provided via nasogastric than gastrostomy tubes because of safety concerns with the latter in immunocompromised children. This systematic review investigated the incidence and type of complications and outcomes in pediatric cancer patients fed by gastrostomy. Methods: Databases were searched for randomized and observational studies investigating the use of any gastrostomy device in children aged <18 years with any cancer diagnosis, including those undergoing BMT. Five cohort and 11 case series studies were included. Owing to clinical heterogeneity, meta-analyses were not performed.Results: Quality of evidence varied, with five studies judged at serious risk of bias and poor quality; however, the remaining 11 were considered to range from moderate to good quality. Across studies, 54.6% of children developed one or more complications, of which 76.6% were classified as minor, 23.4% major. The most frequent complications included inflammation (52% of episodes), infection (42.1%), leakage (22.3%), and granuloma (21%). Evidence regarding infection rates in cancer/BMT patients compared with other disease states was inconclusive.Gastrostomy feeding was associated with improvement or stabilization of nutrition status in 77%-92.7% of children.This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

show abstract

Introduction to interventional oncology: A COG Diagnostic Imaging Committee/SPR Oncology Committee White Paper

Gill

Hawkins

2023

Pediatric Blood & Cancer

View full text Add to dashboard Cite

Interventional radiology (IR) is a valuable resource when caring for pediatric solid tumor patients. As minimally invasive, image-guided procedures become more relied upon to answer challenging diagnostic questions and provide alternative therapeutic options, IR is poised to become a contributing member of the multidisciplinary oncology team. Improved imaging techniques allow for better visualization during biopsy procedures, transarterial locoregional treatments have the potential to deliver targeted cytotoxic therapy while limiting systemic side effects, and percutaneous thermal ablation can be used to treat chemo-resistant tumors of various solid organs. Additionally, interventional radiologists are able to perform routine, supportive procedures for oncology patients that include central venous access placement, lumbar punctures, and enteric feeding tube placements with high levels of technical success and excellent safety profiles.

show abstract

De novo radiologic placement of button gastrostomy: a feasibility study in children with cancer

Abstract: The procedure and devices were well tolerated and mostly effective in our cohort.

Cited by 6 publications

References 29 publications

Gastrostomy tube use in children with cancer

Gastrostomy tube use in children with cancer

Systematic review of gastrostomy complications and outcomes in pediatric cancer and bone marrow transplant

Introduction to interventional oncology: A COG Diagnostic Imaging Committee/SPR Oncology Committee White Paper

Contact Info

Product

Resources

About